Certified by Founder Lodge
Monograph Capital
United Kingdom - London
INVESTOR
1 Disclosed Funding Rounds $16,000,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
With offices in London and San Francisco, Monograph bridges opportunities across North America and the UK/Europe, bringing deep experience, assets and capabilities to help life sciences compa
Company | Date | Round | Raised |
---|---|---|---|
Maxion Therapeutics | February, 21 ,2023 | Series A | $16,000,000 |
Ascend Gene & Cell Therapies | May, 10 ,2023 | Series A | $132,500,000 |
Sudo Biosciences | December, 21 ,2023 | Series B | $116,000,000 |
Nocion Therapeutics, Inc. | March, 06 ,2024 | Series B | $62,000,000 |